The Michael J. Fox Foundation Parkinson's Podcast
The Michael J. Fox Foundation for Parkinson’s Research
Subscribe for coverage and analysis of current neurology/brain research, patient and caregiver profiles, drug development strategy, pioneering nonprofit management and other topics of interest in a wide-ranging series of conversations that include the voices of those affected by Parkinson's as well as clinicians.
What’s in Your Parkinson’s Medicine Cabinet (Ask the MD Podcast)
Movement disorder specialist, lifestyle medicine physician and MJFF Principal Medical Advisor Rachel Dolhun, MD, DipABLM, shares tips on medication management for people at every stage of the disease journey. Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.co/3p02Jw0 The Foundation’s landmark study, the Parkinson’s Progression Marker’s Initiative, also known as PPMI, is recruiting volunteers. Join the study that’s changing
Managing the Hidden Symptoms: Mood and Motivation Changes in Parkinson’s (Webinar Audio)
If depression, anxiety or apathy occur as part of a Parkinson’s journey, it can be easy to feel alone, isolated or unsure of what might bring relief. But there are ways to manage these symptoms. Tune into audio from this Third Thursdays Webinar to hear people living with Parkinson’s share their stories of coping with mood changes as well as a movement disorder specialist and psychiatrist discuss pharmacological and non-pharmacological treatments options. Like our podcasts? Please consider leavin
Your Top Questions on Parkinson’s and Exercise Answered (Ask the MD Podcast)
Movement disorder specialist, lifestyle medicine physician and MJFF Principal Medical Advisor Rachel Dolhun, MD, DipABLM, answers community questions on Parkinson’s and exercise with physical therapist and rehab scientist Cristina Colón-Semenza, PhD. Listen to the audio or watch the video. Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.co/3p02Jw0 The Foundation’s landmark study, the Parkinson’s Progression Marker’s Initiati
Parkinson’s Care Partners: Not Another “Self-Care” Discussion (Webinar Audio)
Being a care partner to someone with Parkinson’s disease (PD) can be a shifting and complex role, as symptoms and life circumstances change. And sometimes, this can lead to stress and even burnout for the care partner. Tune into audio from this Third Thursdays Webinar to hear expert panelists discuss how to navigate care partnership, including everyday strategies to de-stress and find supportive community. Like our podcasts? Please consider leaving a rating or review and sharing the series with
The Role of Diet and Nutrition in Parkinson’s Disease and Brain Health with Puja Agarwal
It is widely known that a healthy diet can provide essential nutrients and lead to a multitude of benefits, but growing evidence has highlighted important links between diet, nutrition, and brain health, particularly related to neurodegenerative disease. In this episode, Dr. Puja Agarwal discusses her research investigating the role that diet and nutrition may play in Parkinson’s disease and other neurodegenerative conditions. Evidence from her studies and the work of others suggests that certai
Developing a Novel App to Improve Speech Intelligibility in Parkinson's Disease with Gemma Moya-Galé
Parkinson's disease significantly impacts various aspects of communication, and this can make it challenging for people with the disease to communicate effectively, be understood by others, and engage in social situations. Dr. Gemma Moya-Galé joins this episode to talk about her work on voice and communication in people with Parkinson’s disease. In particular, she discusses a novel app she and her team are developing, with funding from The Michael J. Fox Foundation, to help people with Parkinson
MJFF Scientists Share How Their Work Could Transform Parkinson's Care
Understanding the biology of Parkinson’s disease (PD) and turning that knowledge into better treatments is a complex undertaking. In this episode of the award-winning Parkinson’s Science POV series, scientists at The Michael J. Fox Foundation (MJFF) discuss how they are tackling this problem from every angle. Whether it’s using cutting-edge imaging to get a picture of the disease in the brain or working with the community to develop better options to treat walking difficulties, our researchers a
Increasing Diversity in Research and Addressing Brain Health Inequities with Monica Rivera-Mindt
Certain populations are disproportionately affected by neurological diseases, including Parkinson's and other neurodegenerative diseases. A lot of work remains to be done to improve brain health outcomes and promote healthy brain aging across the lifespan, particularly for minoritized, underrepresented populations. Including participants from diverse backgrounds in research helps ensure that the results from studies and clinical trials in the field are valid, generalizable, and representative of
Year of Momentum: What Parkinson’s Research Accomplished in 2024 (Webinar Audio)
With two new drugs approved by the FDA, a National Plan signed into law and many advances in our understanding of Parkinson’s disease, 2024 has been a transformative year in Parkinson’s research. Tune into audio from this month’s Third Thursdays Webinar to hear research experts from industry and academia talk with MJFF staff about the latest research on disease biology and emerging therapies. Like our podcasts? Please consider leaving a rating or review and sharing the series with your communit
The Development and Application of the Alpha-Synuclein Seed Amplification Assay with Claudio Soto
Alpha-synuclein plays a key role in the pathophysiology of Parkinson's disease, and researchers have been investigating this protein as a therapeutic target and also as a potential biomarker for the disease. The alpha-synuclein seed amplification assay, developed by Dr. Claudio Soto and colleagues, leverages the self-replicating nature of the misfolded alpha-synuclein proteins that form aggregates in Parkinson's disease. Amplifying misfolded alpha-synuclein can allow researchers and clinicians t
Ask Us Anything About Deep Brain Stimulation Surgery Day
Each person living with Parkinson’s disease (PD) will have a unique journey with their treatments, including the decision to have deep brain stimulation (DBS), which is a surgical procedure to treat Parkinson’s motor symptoms. While DBS isn’t suitable for everyone, it can be helpful in the right person, and it’s a complex, lifelong choice. And although the experience goes far beyond surgery day, brain surgery often looms large in people’s minds as they are contemplating DBS. In this episode, our
An Inside Look at the Edmond J. Safra Fellowship in Movement Disorders with Marcelo Merello and Sergio Castillo-Torres
To help meet the growing global need for more movement disorders specialists, The Michael J. Fox Foundation created the Edmond J. Safra Fellowship in Movement Disorders in collaboration with longtime partner the Edmond J. Safra Foundation. This program supports the training of movement disorders specialists who will provide expert care and drive advances in Parkinson's research. The program is positively impacting early-career clinician-researchers, as well as the centers where they train. These
Hitting Stride: Research Advances on Walking with Parkinson’s (Webinar Audio)
Troubles with gait – slow walking, shuffling steps and foot dragging and more – can be symptoms of Parkinson’s. In audio from this Third Thursdays Webinar, our experts explore the robust research efforts underway to understand and treat gait issues, from physical rehab interventions to deep brain stimulation modifications to wearable robots designed to smooth gait. Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.c
Creating Alpha-Synuclein Cell Lines and Supporting Open Science with Birgitt Schüle
Stem cell models derived from patients with Parkinson’s disease are valuable tools that are helping researchers around the world to better understand the underlying causes of neurodegeneration and to develop biomarkers and new therapies. To maximize the potential impacts of these tools, it is critical that they are developed and shared according to the principles of open science. In her interview, Dr. Birgitt Schüle discusses her work developing alpha-synuclein cell lines, challenges and opportu
Perspectives on Navigating Racial Bias and Stigma in Parkinson's Disease
In this podcast, four people from different backgrounds have a candid conversation on race, stigma and Parkinson’s. They share their experiences trying to find culturally competent medical professionals, overcoming the barriers to research participation, and communicating with their communities about their diagnosis. And they offer tips and advice on finding empowerment through education and advocacy. Like our podcasts? Please consider leaving a rating or review and sharing the series with your
Developing FLEXISyn to Identify and Measure Changes in Alpha-Synuclein in Parkinson's Disease with Judith Steen
New qualitative and quantitative tools are being developed to measure and track changes in proteins relevant for neurodegenerative disease, and these tools have the potential to accelerate drug discovery and clinical trials. In this episode, Dr. Judith Steen discusses her work creating novel qualitative and quantitative tools and workflows at the interface of proteomics and transcriptomics, including their novel FLEXI platform. This platform uses targeted, high- throughput quantitative mass spec
A Conversation on Parkinson’s-Related Hallucinations and Delusions (Webinar Audio)
Parkinson’s disease brings with it many potential symptoms, including hallucinations (seeing things that are not there) and delusions (believing things that are not true). Not everyone will experience these symptoms and not everyone who does will find them bothersome, but it can be a source of uncertainty and concern for people living with the disease. In audio from this Third Thursdays Webinar, our expert panel discusses navigating life with these symptoms and medication and non-medication stra
Clinical Applications of Biomarkers and Large-Scale Collaborative Research with Charles Adler
Substantial research has focused on identifying biomarkers for the diagnosis of Parkinson's disease (PD) as well as monitoring progression of the disease. In developing these biomarkers, it is critical for scientists to consider how the biomarkers will ultimately be used in the clinic and in clinical trials research. In this interview, Dr. Charles (Chuck) Adler shares his perspectives on how biomarkers are currently being used in clinical and research contexts, and what it would take for him to
Investigating Light Therapy For Sleep and Motor Function in People with PD with Beatrix Feigl
Sleep disturbances, such as insomnia, sleep fragmentation, excessive daytime sleepiness, and REM sleep behavior disorder are common in people with Parkinson's disease (PD). Poor sleep quality can also impact other domains of function, including motor function. Prior research has shown that a type of photoreceptor cell in the retina, called melanopsin cells, provide the main light signals to the brain to initiate sleep, and function of these cells is impaired in PD. Dr. Beatix Feigl and her colle
Your Daily Dose: Managing Parkinson’s Medications (Webinar Audio)
Finding the right Parkinson’s treatment plan can be a trial-and-error process. The kind of medication, the dosage, the timing and lifestyle factors are all important pieces of the puzzle. In audio from this Third Thursdays Webinar, our expert panel made up of people living with Parkinson’s disease (PD), a movement disorder specialist and a researcher discuss different medication options, practical tips for finding what works best for you and the latest research on emerging treatments. Like our
The Autophagy-Lysosomal Pathway and Development of Relevant PD Biomarkers with Zhenyu Yue
Though existing evidence supports that dysfunction in the clearing of cellular debris plays an important role in the development of Parkinson's disease, many unanswered questions remain regarding the mechanisms of the autophagy-lysosomal pathway involved in this process. In particular, research in the field has been limited by a lack of reliable, quantitative tests for monitoring autophagy-lysosome activity. In this interview, Dr. Zhenyu Yue describes his research investigating the cellular and
Breathing Through: Mindfulness as a Parkinson's Treatment Tool
Research shows mindfulness and meditation can improve some Parkinson’s (PD) symptoms and help people live a better life with the disease, but it can be tricky to put into practice. In this podcast, you’ll hear from people whose lives have been touched by PD and who use mindfulness to reduce symptoms and stress, and from a researcher who is studying how mind-body strategies can be used to treat Parkinson’s. Tune in for practical tips, advice and a guided meditation you can try at home. You can f
Studying CSF Element Profiles and Tear Fluid as Potential Biomarkers, and Novel and Combined Therapies for PD with Paul Lingor
Evidence supports that dysfunction in the homeostasis of iron and other elements likely contributes to the pathophysiological mechanisms of Parkinson's disease, but we have yet to develop suitable elemental biomarkers for use in diagnosing and monitoring the progression of Parkinson's disease. Dr. Paul Lingor discusses his work in this area to identify patterns of bioelements in CSF that could serve as PD biomarkers. Beyond CSF, he is also examining tear fluid as a potential biomarker source tha
Considering Deep Brain Stimulation: What to Know and Expect (Webinar Audio)
The decision-making process around deep brain stimulation (DBS) to treat Parkinson’s motor symptoms can be a complex and emotional journey. People often have questions about when – and whether – to have the procedure and what the experience is like, from the months of evaluation pre-surgery to surgery day to life with the device. In audio from this Third Thursdays Webinar, our panel of people living with Parkinson’s disease (PD) and a movement disorder specialist share their DBS stories and answ
Current and Emerging Imaging Biomarkers for Diagnosis and Prognosis of PD and Atypical Parkinsonism with Antonio Strafella
Identifying reliable biomarkers for the diagnosis and prognosis of Parkinson's disease and atypical parkinsonism would have substantial impacts on clinical trials and clinical practice. A particularly active area of research is the development of novel molecular imaging biomarkers that can be used in combination with common neuroimaging approaches. Dr. Antonio Strafella discusses current practices for using molecular imaging biomarkers in research and in the clinic, the process of developing new
Building on the Biomarker Breakthrough: What We’re Working on Now
Just over a year ago, there was a major breakthrough in Parkinson’s disease (PD) research – a tool that could detect abnormal alpha-synuclein protein in the spinal fluid of people living with PD even before onset of symptoms. This discovery is already impacting the ways scientists conduct and think about Parkinson’s research. Tune into this episode of our award-winning “Parkinson’s Science POV” series to learn how researchers are using the test to better understand disease biology and what the
Examining Links Between Environmental Exposure, Poor Olfaction, and Parkinson's Disease with Honglei Chen
Prior studies have established links between poor olfaction and Parkinson's disease, and impaired sense of smell is a common prodromal symptom of Parkinson's disease. The causes and mechanisms of prodromal neurodegeneration are actively being researched. However, environmental exposure to pesticides or other chemicals may trigger or modify the course of neurodegeneration, potentially leading to the development of Parkinson's disease over time. In this episode, Dr. Honglei Chen shares his researc
You Want to Volunteer for Parkinson’s Research: Now What? (Webinar Audio)
You might be interested in stepping forward for science to play a role in the next breakthrough in Parkinson’s research, but still have questions about how to actually participate. How do you pick the right study for you? How do you balance your life logistics and your medical care considerations? What rights do you have when you participate in a study? In audio from this Third Thursdays Webinar, our panel of people living with Parkinson’s and research experts discuss the practicalities and bene
Developing Interventions to Improve Gait and Increase Physical Activity in Parkinson’s Disease with Gammon Earhart
Gait impairments such as slow speed, small steps, and high variability from step to step are common in people with Parkinson's disease, and these changes begin to occur early in the course of disease. Freezing of gait may develop later for some individuals, and it has been linked to falls and other adverse outcomes. When the quality of walking declines, it can lead to a reduction in the quantity of walking and overall physical activity, which is also related to poorer health outcomes. To prevent
Studying Basal Ganglia Circuits and Developing Deep Brain Stimulation Protocols for Longer-Lasting Effects with Aryn Gittis
Improving our understanding of the complex neural circuits involved in normal function of the basal ganglia and other parts of the brain impacted by Parkinson's disease is critical for developing more targeted and more effective treatment approaches. In this episode, Dr. Aryn Gittis discusses her research examining how the activity of specific basal ganglia circuits relates to motor control in both health and pre-clinical models of movement disorders like Parkinson's disease. She describes new r
When Parkinson’s Hurts: Treatments for Managing Pain (Webinar Audio)
Many people living with Parkinson’s disease (PD) experience pain as a non-motor symptom. Pain can arise from stiff muscles, dystonia, nerve pain and even the disease progression itself. It’s a symptom that some find difficult to talk about, but there are options for people to find relief. In audio from this Third Thursdays webinar, listen to our expert panel of people living with PD, movement disorder specialists, and an integrative pain specialist discuss pain and Parkinson’s – why it happens,
Innovative Fellowship Program is Training Tomorrow's Parkinson's Leaders with Rachel Dolhun
Demand for movement disorder specialists continues to grow, but not enough neurologists are receiving focused training in Parkinson’s and related conditions in order to meet the current and projected needs in the U.S. and around the world. In collaboration with longtime partner the Edmond J. Safra Foundation, The Michael J. Fox Foundation created the Edmond J. Safra Fellowship in Movement Disorders with the goal of growing the global base of movement disorders specialists. In this episode Dr. Ra
What I Wish I Had Known at Diagnosis
In this episode, hosted by Larry and Rebecca Gifford, members of The Michael J. Fox Foundation’s Patient Council and their care partners share their honest reactions to their diagnosis — from panic and denial to sadness and loneliness. This group of men and women of different ages and backgrounds offers words of wisdom about what to consider, what they’ve lost and what they’ve gained – and you’ll be surprised to hear how, for some, what they’ve gained is more than what they lost. Like our p
Real Talk from Women Living with Parkinson’s
In this raw and emotional conversation, four women with Parkinson’s living in four different countries discuss the challenges faced because of delayed diagnosis, hormonal changes, lack of information and treatment, research inequity and gender biases. They share how they live better with the disease by advocating for themselves with their health care team and how they empower other women through awareness and activism. Like our podcasts? Please consider leaving a rating or review and sharin
Evidence Linking Parkinson's Disease Risk and Environmental Exposure to Trichloroethylene (TCE) with Sam Goldman
Trichloroethylene (TCE) and related chemicals like perchloroethylene (PCE) have been used widely for a variety of commercial purposes over the past century, and these chemicals are prevalent in the air, water, and soil. Over the past several decades, mounting evidence has been published linking exposure to TCE/PCE with adverse health effects, including cancer and Parkinson's disease. In this episode, Dr. Sam Goldman discusses his research on environmental risk factors for Parkinson’s disease, fo
Let’s Talk Taboos: Hard-To-Discuss Parkinson’s Symptoms (Webinar Audio)
Living with Parkinson’s comes with a variety of symptoms, some of which can be unexpected, and frankly, embarrassing. Drooling, bladder issues and sexual dysfunction are hard to talk about, even with loved ones or your doctor – and can affect your self-image, your intimate relationships or the way you move through the world. In audio from this Third Thursdays webinar, listen to our expert panel of people living with Parkinson’s, a care partner and a movement disorder specialist discu
New Advances in Neurosurgical Interventions for Parkinson's Disease with Doris Wang
For over a century, different surgical interventions have been explored to address symptoms of Parkinson's disease, and researchers are continuing to innovate and improve surgical treatments today. With new technology and an ever-expanding understanding of the function of the nervous system and the pathophysiology of Parkinson's disease, neurosurgical interventions are becoming more effective and more personalized. Dr. Doris Wang joins us in this episode to discuss her work using focused ultraso
Accelerating Discovery by Developing and Distributing Research Tools with Nicole Polinski
The Michael J. Fox Foundation for Parkinson's Research established its Research Tools Program to address gaps in the field and common challenges surrounding the development of reagents and models that slowed the initial stages of promising research projects. In collaboration with many partners and stakeholders, the Research Tools Program helps ensure that scientists around the world have access to high-quality reagents, models, and more. These tools have been instrumental in launching novel rese
Everyday Exposures to Parkinson’s: Environmental Connections to the Disease (Webinar Audio)
The biology behind what causes Parkinson’s is complex, with only about a quarter of cases with clear genetic drivers. The environment – where you live, the air you breathe, the food you eat, the world around you – plays a key role in PD. Emerging research is showing environmental exposures to things like pesticides and pollution may interact with a person’s genetics and contribute to the disease. And there’s a myriad of other factors still being investigated, from the forces that drive your acce
The Importance of Sex and Gender Factors in Neurodegenerative Disease Research and Care with Antonella Santuccione Chadha
Increasing evidence supports the presence of sex and gender differences in neurodegenerative conditions, including Alzheimer's disease and Parkinson's disease. There is a critical need to more closely examine sex and gender differences in all stages of research, therapeutic development, and clinical treatment to enable better outcomes through precision medicine approaches. This episode focuses on the relevance of sex and gender factors in Parkinson's disease and efforts to transform scientific r
Understanding Genetics, Pathology, and Progression in Parkinson's Disease and Atypical Parkinsonian Syndromes with Huw Morris
Atypical Parkinsonian Syndromes, such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia with Lewy bodies are often initially diagnosed as Parkinson's disease. Incorrect, incomplete, or delayed diagnoses are barriers to beginning the most appropriate treatment early in the disease course. More research is needed to facilitate early diagnoses, understanding of disease pathogenesis, and monitoring of disease progression. However, l
Therapies for Tomorrow: How Better Clinical Trial Design Leads to Better Treatments (Webinar Audio)
The drug development pipeline is key to bringing new therapies to people with Parkinson’s disease (PD). With major breakthroughs in research in the past year, including a new biomarker for PD, The Michael J. Fox Foundation’s Parkinson’s Progression Markers Initiative (PPMI) study and other initiatives can be leveraged to create better designed trials. This audio from our Third Thursdays Webinar features a conversation about all the ways clinical trial design is changing, and why leaders in the s
Examining the Proposed Biological Definition of Neuronal Alpha-Synuclein Disease and Staging System with Lana Chahine
For many years, Parkinson's disease and dementia with Lewy bodies have been defined using clinical features. With recent advances in biomarkers, particularly the alpha-synuclein seed amplification assay that allows us to detect misfolded and aggregated alpha-synuclein in cerebrospinal fluid, it is now possible to identify the presence of pathological neuronal alpha-synuclein in living patients. With input from diverse stakeholders, a new biological definition of neuronal alpha-synuclein disease
Dating and New Relationships after a Parkinson’s Diagnosis
Dating and beginning new relationships with Parkinson’s involve distinct challenges, joys and fears. In this frank and funny podcast, our experts discuss how they face considerations like building and maintaining confidence, disease disclosure, and the importance of self-knowledge and self-care in new relationships. They remind us all that no matter what we’re facing, dating and finding love can be fun and fulfilling. Like our podcasts? Please consider leaving a rating or review and sharing
Managing Risk for Drug Discovery and Development in Parkinson's Disease with Kalpana Merchant
There is a pressing need to develop safe and effective disease-modifying and symptomatic treatments for Parkinson's disease. Through improvements in our understanding of the pathophysiology of the disease, as well as genetic risk factors, new potential treatment targets have emerged. However, bringing a promising new compound from the lab through all of the steps of drug development is a long, difficult, and resource-intensive process. In recent years, collaborative efforts and advances in bioma
New Year, New Moves! Explore Exercise for Life with Parkinson’s (Webinar Audio)
We know exercise is important for people with Parkinson’s. Once you’ve decided to move more, what next? In this audio from our Third Thursdays Webinar, our experts discuss strategies for making exercise a meaningful part of your life. They present ways to make time for exercise and to make the most of it, including being aware of different types, frequencies and intensities. This discussion will help you find a way to get moving and stay motivated. Like our podcasts? Please consider leaving
How MJFF “De-Risks” PD Drug Development Pipeline
One key pillar of The Michael J. Fox Foundation’s research strategy is a focus on “de-risking" potential treatments for Parkinson’s disease. This episode of our award-winning “Parkinson’s Science POV” series explains how lowering the risk associated with developing new therapies leads to a more robust pipeline of treatments. The episode details several recent successes of the strategy. Like our podcasts? Please consider leaving a rating or review and sharing the series with your network. ht
Using Neuroimaging and Biomarkers to Improve Neurodegenerative Disease Diagnosis and Assessment with John Seibyl
In neurodegenerative conditions such as Parkinson's disease (PD), patients often do not receive a diagnosis until the hallmark motor symptoms begin to manifest. This can be a decade or more after substantial changes start occurring in the brain. A major goal of the PD research field has been to develop methods for earlier detection and intervention. Over the years, there have been substantial advances in neuroimaging techniques and biological biomarkers that have allowed us to more accurately id
Tools for Diagnosing and Visualizing Parkinson’s Disease (Webinar Audio)
Doctors have been using DaTscan brain imaging as a tool to help diagnose the Parkinson’s disease (PD) for more than a decade, but even people who know a lot about the disease often still have questions about its role — and the role of other imaging tools — in diagnosis and care. What’s a DaTscan, and how does it relate to PET, SPECT and MRI? When is a DaTscan or other brain imaging tool used in PD? Are there any risks? In this audio from our Third Thursdays Webinar, experts and people with
Impacts and Goals of the Global Parkinson's Genetics Program with Christine Klein
A substantial portion of people with Parkinson's disease (PD) have a family history of the disease, and new findings continue to improve our understanding of relevant genetic variants. These discoveries are key for clarifying the mechanisms that lead to Parkinson's disease as well as the development of new therapies. The Global Parkinson's Genetics Program (GP2) was established to gather and integrate genetic and clinical data from diverse participants around the world to expand our knowledge of
Having Happy Holidays with Parkinson’s
The holidays can be a time of joyful celebration with those we love. They may also come with the stress of travel, disruptions to your regular routine or even loneliness. For those living with Parkinson’s disease (PD), or those taking care of someone they love with the disease, these feelings can be intensified. This podcast offers tips to people living with PD, as well as their care partners, friends and family, for how to prepare — mind, body and suitcase — to make your holidays happy. &
The Role of Inflammation and Immune Responses in Neurodegeneration with Malú Gámez Tansey
A growing body of evidence is expanding our understanding of the links between inflammation, our immune responses, brain health, and neurodegeneration. In particular, several genes associated with Parkinson's (including LRRK2) are known to be involved in inflammation, and peripheral inflammation has been shown to influence brain function and contribute to the development of neurodegenerative diseases. Better understanding the roles of inflammation and our immune responses in Parkinson's disease
Elucidating the Pathobiology of LRRK2 in Parkinson's Disease with Dario Alessi
Mutations in the LRRK2 gene were first linked to Parkinson's disease (PD) risk in 2004. Since then, researchers from around the world have advanced our understanding of the mechanisms through which LRRK2 may contribute to PD, leading to the development of three potential LRRK2-targeted therapies that are now being evaluated in clinical trials. Along with colleagues and collaborators, Dr. Dario Alessi has pioneered new research and approaches that have aided in the development of drugs to inhibit
A Year Like No Other in Parkinson’s Research: 2023 in Review (Webinar Audio)
In a year of remarkable progress for the Parkinson’s field, we’re entering a new era for better understanding the biology of the disease, with the identification of a breakthrough biomarker accelerating new therapeutics through the clinical pipeline and legislators on Capitol Hill moving toward legislation that unites the federal government on a mission to treat, prevent and cure Parkinson’s disease. What does this progress mean for researchers studying Parkinson’s and for those living with
New Frontiers in Deep Brain Stimulation Research for Parkinson’s disease with Michael Okun
For decades, researchers, clinicians, and industry professionals have continued to study and optimize deep brain stimulation (DBS) with the goal of providing the best possible personalized treatment for Parkinson’s disease (PD) and other neurological conditions. In this episode, Dr. Michael Okun joins us to discuss his research and some of the recent advances in deep brain stimulation and other areas. He draws from his extensive research and clinical experience applying DBS and neuromodulation t
Genetics Discovery Underscores Importance of Diversity in Parkinson’s Disease Research
In a groundbreaking discovery earlier this year, a global consortium found a new variant in the GBA gene that is associated with a higher risk of Parkinson’s disease (PD) for people of African ancestry. The finding marks the first African ancestry-specific genetic risk factor for Parkinson’s disease. In this podcast, researchers share the human stories behind the discovery, which underscores the importance of international collaboration and the participation of underrepresented communities in re
Understanding Sleep Differences in Parkinson’s Disease with Dr. Amy Amara
Sleep impacts our lives in many different ways, and Dr. Amy Amara joins us in this episode to discuss her career and findings from her research on sleep in Parkinson’s disease (PD). She shares her insights on the characteristics of sleep in people with Parkinson’s disease, how sleep can be impacted by exercise, medications, and deep brain stimulation, and how studying rapid eye movement (REM) sleep behavior disorder may be important for developing early treatments before PD motor symptoms manife
Ask Us Anything: Answers to Your Questions about Gut Health and Parkinson’s (Webinar Audio)
People with Parkinson’s disease (PD) have lots of questions about probiotics, prebiotics, laxatives and fiber. That’s because constipation and bloating are some of the more bothersome but less talked about symptoms of PD. In this audio from our Third Thursdays Webinar, experts and people with PD discuss effective ways for managing constipation and other gut-related symptoms. You’ll also learn about emerging treatments for constipation, the gut-brain connection and why the gut is linked to Parkin
Industry Contributions and Collaborations in Parkinson's Research with Karoly Nikolich
In this episode, serial entrepreneur Dr. Karoly Nikolich shares his perspectives on the industry side of the state of neuroscience, as well as areas of opportunity and the role of industry in advancing the field. He also discusses recent major breakthroughs, the importance of industry partnerships, including collaborations with The Michael J. Fox Foundation (MJFF), and how he is working to advance Parkinson's disease research through his work at Alkahest and other endeavors. Karoly is a scientif
The Parkinson's Research Landscape and the Role of MJFF with Brian Fiske and Mark Frasier
New research advances are expanding our knowledge of Parkinson's disease and bringing us closer to the ultimate goals of new treatments, effective cures, and disease prevention. In this introductory episode, you'll hear from Dr. Brian Fiske and Dr. Mark Frasier, Co-Chief Scientific Officers at The Michael J. Fox Foundation for Parkinson's Research (MJFF). During the conversation, they provide their perspectives on the state of the field of Parkinson's disease research, describe new advances in b
Finding Your Way: Working through Emotions in Early Years with Parkinson’s (Webinar Replay)
Shock, doubt, anxiety — a diagnosis of Parkinson’s can trigger these and many other difficult emotions. This replay of audio from our Third Thursdays Webinar features a conversation among people with Parkinson’s about how they processed the emotional aftermath and navigated the early years following their diagnosis. We also hear from a psychologist who specializes in Parkinson’s about what she’s learned about how people deal with this life-changing diagnosis and ways to manage the emotions in a
Finding Your Way: Working through Emotions in Early Years with Parkinson’s (Webinar Replay)
Shock, doubt, anxiety — a diagnosis of Parkinson’s can trigger these and many other difficult emotions. This replay of audio from our Third Thursdays Webinar features a conversation among people with Parkinson’s about how they processed the emotional aftermath and navigated the early years following their diagnosis. We also hear from a psychologist who specializes in Parkinson’s about what she’s learned about how people deal with this life-changing diagnosis and ways to manage the emotions in a
Too Much or Not Enough: Dyskinesia and “Off” Time in Parkinson's (Webinar Replay)
In this replay of audio from our Third Thursdays Webinar, Michael J. Fox Foundation Patient Council member Larry Gifford leads a discussion on common Parkinson’s issues — dyskinesia and "off" time — and how to treat them. Like our podcasts? Please consider leaving a rating or review and sharing the series with your network. https://apple.co/3p02Jw0 Whether you have Parkinson’s or not, you can help move research forward. Join the study that’s changing everything. Find out more at michaeljfox.org
Reporting on Stem Cells for Parkinson’s
Stem cells have grabbed headlines for decades. Now, at last, they are starting to deliver on their therapeutic promise, with multiple stem cell therapies in clinical trials for Parkinson’s disease. This episode of our award-winning “Parkinson’s Science POV” series brings us up to date on these trials, including how scientists are using stem cells to replace dopamine, the chemical that’s lost in Parkinson's disease. Like our podcasts? Please consider leaving a rating or review and sharing the ser
Genetics and Parkinson’s: Understanding the Role of Gene Therapy in a Cure (Webinar Audio)
What do you know about gene therapy and its potential for treating Parkinson’s? In this audio from our Third Thursdays Webinar, you’ll learn what exactly gene therapy is and how it works, who gene therapy might work for and the role of genetic testing. You’ll also get a status report on investigations into gene therapy for Parkinson’s. Panelists include experts in the field as well as a person with Parkinson’s and her care partner.
Like our podcasts? Please consider leaving a rating or review
Digestible Tips: Your Gut and Parkinson’s
How’s this for a dinnertime conversation starter… did you know that what happens in your gut can have an impact on your brain health? Some experts even call the gut “the second brain” because of its huge community of microbes and large nerve network that links the gut to brain disease, like Parkinson’s.
Join our panel of experts who cover the latest research on this link between gut and brain health. And tune in as they discuss common gut symptoms of Parkinson’s and what you can do to manage th
From Low Blood Pressure to Bladder Problems: A Look at Lesser-Known Parkinson’s Symptoms (Webinar Replay)
Many people with Parkinson’s experience autonomic symptoms, like bladder problems, low blood pressure and constipation that can be hard to talk about. In this audio from our Third Thursdays Webinar replay, experts and patients open a dialogue on these issues and share ways to treat them.
Like our podcasts? Please consider leaving a rating or review and sharing the series with your network. https://apple.co/3p02Jw0
Whether you have Parkinson’s or not, you can help move research forward. Join t
Ask MJFF Anything: Your Questions for Our Scientists
In the latest installment of our award-winning “Parkinson’s Science POV” series, MJFF’s Maggie Kuhl sits down with Mark Frasier and Brian Fiske, Chief Science Officers at MJFF, in an “Ask MJFF Anything” edition of our podcast. These experts cover a variety of questions from our community about Parkinson’s disease (PD) therapies and treatments, the recent biomarker breakthrough and more. Get answers on topics ranging from how exercise helps improve balance, to what the new biomarker breakthrough
Get Moving: Exercising for a Healthy Brain (Webinar Audio)
Have you ever wondered what’s the best exercise for your brain? Listen as our expert panel breaks down approachable tips to add more movement into your day-to-day, Parkinson’s-friendly exercises to try right now and the science behind the benefits of working up a sweat.
Join hundreds of Parkinson’s community members June 17 weekend for our annual Virtual Run/Walk. Register and learn more at www.michaeljfox.org/runwalk
Like our podcasts? Please consider leaving a rating or review and sharing th
If Not Us, Who? Humans behind a Biomarker Breakthrough
Faith and science are not often discussed together, but science requires a leap of faith. A few years ago, MJFF staff scientists, Samantha Hutten, PhD and Katie Kopil, PhD never would have guessed that a leap of faith and a cold call to a researcher in Texas would lead to a tool that, for the first time, can detect Parkinson’s in people who have not yet shown symptoms. With the help of the countless community members taking part in the PPMI study, these researchers found a biomarker for Parkinso
Major Research Breakthrough: A New Biomarker for Parkinson's (Webinar Audio)
In April, The Michael J. Fox Foundation (MJFF) announced a major biomarker breakthrough, opening a new chapter for Parkinson’s research — with the promise of better drug development and care for all people and families living with the disease. With the new test, validated by MJFF’s Parkinson’s Progression Markers Initiative (PPMI), researchers can objectively define and monitor this pathology for the first time in the living body. Experts explain the promise this research holds for all people li
Trouble Sleeping? What to Know about Acting Out Dreams and Other Sleep Issues (Webinar Replay)
Some people act out their dreams while asleep. They may punch, kick, yell or even fall out of bed. This sleep problem can be linked to Parkinson’s and other brain diseases. In this episode, experts share why sleep issues happen and what you can do to manage them.
If you or your bed partner have sleep issues — whether you have Parkinson’s or not — you can play a critical role in research. Join the study that's changing everything at michaeljfox.org/podcast-ppmi
More about The Michael J. Fox Fou
What You Need to Know about Sleep, Aging and Parkinson's
Did you know that RBD – REM sleep behavior disorder, or acting out dreams -- can be an early indicator of Parkinson’s? Many people develop sleep issues as they age — with and without PD.
Join host Larry Gifford in a rich discussion with expert Stephen Joza, MD, PhD; Allen Dance, recently diagnosed with RBD; and Richie Rothenberg, patient advisor to The Michael J. Fox Foundation (MJFF), with his care partner Julie Merson, on why sleep is important, strategies to tackle sleep problems and the impo
One Step at a Time: Managing Gait and Balance Issues in Parkinson's (Webinar Audio)
From freezing to shuffling and everything in between, gait and balance issues can impact people with Parkinson’s at all stages of their journey. In this episode, listen as experts discuss emerging research and tips for people and care partners to improve mobility, prevent falls and maintain independence day to day.
The Michael J. Fox Foundation’s landmark research study is focused on learning more about how Parkinson’s starts, changes over time and how to stop it. Study volunteers are urgently
Food for Thought: Answering Your Questions on Diet, Brain Health and Parkinson's
For many, the word “diet” has negative associations: cutting out the foods you love, not enjoying what you eat or following strict rules about what you can or can’t eat. But diet is a way of life. And you can still boost brain health or manage Parkinson’s with your favorite family recipes, dinner out with friends and even the salty or sweet snacks you crave most. The Michael J. Fox Foundation’s Rachel Dolhun, MD, fellowship-trained movement disorder specialist, board-certified neurologist and l
Eating to Boost Brain Health and Ease Symptoms (Webinar Audio)
What foods are best for you? Whether you have Parkinson’s disease, or are concerned you might develop it, food and nutrition play a critical role in brain health. Our expert panel of Parkinson’s physicians and nutritionists shares effective ways to manage symptoms through nutrition and mobility modifications to make food preparation and eating easier.
Learn more about diet and nutrition in our new free guide, available at michaeljfox.org/guides.
Our landmark research study, the Parkinson’s Pro
Podcast: What Comes Next? Living with Parkinson’s Years after Diagnosis (Webinar Replay)
There are social, emotional and physical changes you may notice after living with Parkinson’s for some time. In this episode replay, experts discuss tips for managing symptoms, finding support and living well with Parkinson’s disease.
Our landmark Parkinson’s Progression Markers Initiative is open to anyone over age 18 in the U.S. Join the study that could change everything at michaeljfox.org/podcast-ppmi
Like our podcasts? Please consider leaving a rating or review and sharing the series with y
Navegando el Viaje Emocional de un Diagnóstico de Parkinson (seminario virtual: grabación de audio)
Un diagnóstico de Parkinson puede traer muchas emociones diferentes: negación, ira, tristeza, frustración. Es importante saber que no importa qué emociones sientas, no estás solo. Escuche a los expertos, personas con Parkinson y un especialista en trastornos del movimiento, hablar sobre cómo navegar por las emociones y el viaje viviendo con la enfermedad. Este episodio es de nuestro último seminario virtual en español y ofrece reflexiones personales sobre los pasos que las personas y familiares
2022 in Review: Progress Toward Better Treatments and Prevention (Webinar Audio)
The Parkinson’s community often asks, “What new treatments are in the pipeline?” In this episode, experts discuss the latest approaches in treating the spectrum of Parkinson’s, from early diagnosis to advancing disease. They also highlight the latest tools to predict and measure Parkinson’s and critical steps toward prevention.
Recently diagnosed with Parkinson’s? You can play a critical role in the Parkinson’s Progression Markers Initiative (PPMI) study. Learn more at michaeljfox.org/podcast-
Podcast: Deep Brain Stimulation: Is It Right for Me or My Loved One? (Webinar Replay)
Many people and families with Parkinson’s wonder if deep brain stimulation (DBS) — a surgical procedure for Parkinson’s — is a possible treatment option for them. In this episode replay, experts discuss who should consider DBS; potential benefits and risks; and the latest advancements in DBS research.
If you’ve recently been diagnosed with Parkinson’s, you can play a critical role in our landmark Parkinson’s Progression Markers Initiative (PPMI) study. Get started at michaeljfox.org/podcast-newl
From Diagnosis On: My First Days with Parkinson’s
A Parkinson’s diagnosis can bring many different emotions — denial, anger, sadness, frustration. It’s important to know that no matter what emotions you feel, you’re not alone. Listen as people with Parkinson’s and their loved ones discuss how they’ve navigated emotions in the early years with Parkinson’s disease. This podcast episode offers personal reflections on steps people can take toward acceptance and real-world advice for those recently diagnosed and beyond.
If you’ve been diagnosed with
Podcast: Public Policy and You: How to Become a Parkinson’s Advocate (Webinar Audio)
Public policy plays an important role in speeding a cure for Parkinson’s. In this episode, experts discuss ways to become a Parkinson’s advocate and how you can reach out to your elected officials to help influence change on behalf of the Parkinson’s community. Experts also highlight the first-ever legislation solely dedicated to ending Parkinson’s disease.
Ask your Representative to support The National Plan to End Parkinson’s Act at michaeljfox.org/national-plan
Recently diagnosed with Parkins
Podcast: Virtual Checkup: How Telehealth Brings Parkinson's Care to You (Webinar Audio)
Many people with Parkinson’s consider telehealth a useful tool for getting care. But for some, the technology or visit may be tough to navigate. In this episode, experts discuss how to make the most of a virtual visit with a doctor and the impact of telehealth on research and care.
Recently diagnosed with Parkinson’s? You can play a critical role in the Parkinson’s Progression Markers Initiative (PPMI) study. Connect with the PPMI team at michaeljfox.org/podcast-ppmi-sites
The online part of PPM
Making Strides: Treatments and Technology for Walking Problems in Parkinson's
Walking is a complex skill. So, shares Catherine Kopil, PhD, in the third episode of our “Parkinson’s Science POV” podcast series.
Gait requires a symphony of connections between the brain and body, which makes it one of the hardest Parkinson’s symptoms to treat. Kopil, MJFF Senior Vice President of Clinical Research, and Chief Scientific Officer Mark Frasier, PhD, discuss progress toward understanding the neuroscience of gait challenges, such as walking, balancing, shuffling steps and freezing
From Low Blood Pressure to Bladder Problems: A Look at Lesser-Known Parkinson’s Symptoms (Webinar)
Parkinson’s can affect the automatic and involuntary functions our bodies perform, like heartbeat and digestion. In this episode, experts discuss common but lesser-known Parkinson’s symptoms — including bladder problems, constipation, low blood pressure and sweating — and what you can do to treat them.
Recently diagnosed with Parkinson’s? You can play a critical role in the Parkinson’s Progression Markers Initiative (PPMI) study. Connect with the PPMI team at michaeljfox.org/podcast-ppmi-sites
T
A Special Conversation in Honor of Father’s Day: Adult Children Reflect on Having a Father with Parkinson’s
In honor of Father’s Day, The Michael J. Fox Foundation (MJFF) is sharing a special podcast episode between three adult children who discuss how they each have navigated having a father with Parkinson’s disease.
This Father’s Day and beyond, MJFF celebrates the experiences of patients, loved ones, researchers, advocates and supporters — speeding progress toward a cure. The Foundation’s landmark study, the Parkinson’s Progression Markers Initiative (PPMI), is enrolling parents, brothers and siste
What's in Your DNA? Understanding Parkinson's Genetics (Webinar)
What is the science behind genetic inheritance that increases the chance of getting Parkinson’s disease (PD) later in life? In this episode, experts explain what genetic mutations are, those that are mostly seen in people with PD and the benefits of genetic testing.
Join the study that could change everything at michaeljfox.org/podcast-ppmi.
Like our podcasts? Please consider leaving a rating or review and sharing the series with your network. apple.co/3p02Jw0
Your Elected Officials, Your Voice: Coming Together to Speed a Cure
Did you know the government plays an important role in helping find a cure for Parkinson’s, and in caring for those living with the disease? In this episode, Michael J. Fox Foundation policy experts and grassroots advocates discuss the importance of telling your story and building relationships with elected officials who represent you in the halls of power across the United States.
You can help lawmakers understand what matters to people with Parkinson’s. Join our policy network today at michae
Podcast: New to Parkinson’s? Steps to Take Today (Webinar Replay)
Navigating a Parkinson’s diagnosis can be challenging, but you’re not alone. In this episode replay, experts share practical tips for managing the early years of Parkinson’s disease.
If you’ve recently been diagnosed with Parkinson’s, you can play a critical role in our landmark Parkinson’s Progression Markers Initiative (PPMI) study. Connect with the study team today at michaeljfox.org/podcast-ppmi-sites.
Anyone over age 18 in the U.S. — with Parkinson’s, at any stage, or without — can join the
Testing, Testing – How Doctors and Scientists Detect Parkinson’s
How is Parkinson’s diagnosed? Tracked? Importantly, predicted? In the second episode of our “Parkinson’s Science POV” podcast series, MJFF Chief Scientific Officers discuss progress toward better tests for Parkinson’s disease, including a recent report of a brain scan of a key Parkinson’s protein. They discuss imaging, fluid measures and wearable devices and how these objective tools could speed new treatments and improve care.
Much of this work and findings stem from our landmark Parkinson’s P
Parkinson’s Disease and Acting Out Your Dreams (Ask the MD Podcast)
We all dream when we sleep. Some don’t remember dreams. Others clearly recall what they did, how they felt, and who else was there. Still others unintentionally act out their dreams. They may imagine catching a touchdown pass, running from a wild animal, or fending off an enemy. In this episode, our on-staff movement disorder specialist speaks with a couple about their experience with acting out dreams, called REM sleep behavior disorder.
If you or your bed partner act out your dreams — whether
Parkinson’s Pillow Talk: An Open Conversation on Sex, Sleep and Intimacy
Sexual problems are common in people with Parkinson's, but they can be difficult to talk about. In this episode, experts discuss how Parkinson’s and associated symptoms like sleep changes impact relationships and they share strategies for improving physical and emotional intimacy.
A deeper understanding of Parkinson’s disease biology could improve every available treatment. You can help us achieve that. Our landmark Parkinson’s Progression Markers Initiative is open to anyone over age 18 in the
Diet, Exercise and Other Strategies for Living Well as You Age (Webinar)
People with Parkinson's often ask how diet and exercise fit into their overall care plan. In this episode, experts share what you can do today to eat healthier, exercise, boost brain health and live well as you age.
Our landmark Parkinson’s Progression Markers Initiative is open to anyone over age 18 in the U.S. Join the study that could change everything at michaeljfox.org/podcast-ppmi
Like our podcasts? Please consider leaving a rating or review and sharing the series with your network. apple.
Three Reasons to Be Optimistic about Parkinson’s Therapies for All Stages of Disease
Parkinson’s disease changes: its biology and symptoms start even before the cardinal movement issues and evolve decades after diagnosis. In the first episode of our new podcast series “Parkinson’s Science POV,” MJFF Chief Scientific Officers discuss strategies to stop disease progression at every stage. This episode covers our Foundation’s approach to preventing cognitive changes and falls and to moving toward a world where no one receives a diagnosis of Parkinson’s disease.
You can play a part
PPMI: The Study that Could Change Everything (Webinar)
Over the past decade, The Michael J. Fox Foundation’s landmark Parkinson’s Progression Markers Initiative has changed how research is done and what scientists know about the brain. Listen as experts discuss the study’s expansion and why now it needs you.
PPMI is open to anyone over age 18 in the U.S. Join the study that could change everything at michaeljfox.org/podcast-ppmi
Recently Diagnosed with Parkinson’s? Why Your Participation in Research Could Speed a Cure
People early in their disease course are valuable partners in research working toward cures. Experts discuss why this is so important for The Michael J. Fox Foundation’s landmark Parkinson’s Progression Markers Initiative (PPMI) and the critical role you can play in research.
Recently diagnosed with Parkinson’s? Connect with the PPMI team today at michaeljfox.org/podcast-ppmi-sites
PPMI is open to anyone over age 18 in the U.S. Join the study that could change everything at michaeljfox.org/podc
Podcast: Steps Closer to Stopping Parkinson's: 2021 Research Review (Webinar)
Hear expert panelists discuss the latest advancements in Parkinson’s research for our 2021 research review webinar.
“Progress on the Path to the Cure” Research Roundtable Recap
In this podcast, we recap the discussion from our Research Roundtable's expert panel of scientists, program leaders and a person with Parkinson’s.
Progress on the Path to a Cure
...
Podcast: Too Much or Not Enough: Dyskinesia and "Off" Time in Parkinson's (Webinar)
Hear our panelists discuss common Parkinson’s issues — "off" time and dyskinesia — and how to treat them.
Parkinson’s “Off” Time: What It Looks Like, and How to Manage It
What is an “off” period in Parkinson’s? Why does it look so different from person to person? And how do you manage these episodes? Experts discuss steps to work with your doctor and care partners to manage these times when medication is wearing off between doses.
Podcast: Do You Love Someone Who Has Parkinson’s? (Webinar)
Hear our panelists discuss life with Parkinson’s from a loved one’s perspective.
The PD Avengers Podcast Takeover: Meet Global Parkinson’s Organizations and How They Can Help You (Part 2)
Tune in to part two of this podcast takeover as the global advocacy group — the PD Avengers — highlights more Parkinson’s organizations from all over the world. Connect with new groups, learn about their mission and find resources that can support you and your family in your journey with the disease.
The PD Avengers Podcast Takeover: Meet Global Parkinson’s Organizations and How They Can Help You (Part 1)
Ever wondered why there are so many Parkinson’s organizations around the world? Join the PD Avengers — a global advocacy group — as they take over MJFF’s podcast to understand what sets each organization apart, and how you can get involved today.
Podcast: What Comes Next? Living with Parkinson’s Years after Diagnosis (Webinar)
A brief summary of this episode
Podcast: Deep Brain Stimulation: Is It Right for Me or My Loved One? (Webinar)
Hear expert panelists discuss who should consider deep brain stimulation, a surgical procedure for Parkinson’s.
Will You Be My Buddy? Finding Mentors, Friends and Parkinson's Support
Learn about how you can join the Foundation’s new online community — the Parkinson’s Buddy Network — to build meaningful connections with other people and families navigating the disease.
Podcast: You’re Not Alone: Tips for Building Connections in the Parkinson’s Community (Webinar)
Hear expert panelists offer ways to manage isolation and loneliness and tips for creating meaningful community connections.
Podcast: Volunteering for Parkinson’s Research: What to Know and Expect (Webinar)
Hear our expert panelists discuss the benefits and risks of participating in Parkinson’s research.
Myths about Levodopa (Ask the MD Podcast)
Hear from our on-staff movement disorder specialist about the latest in Parkinson’s care and research.
Podcast: Brain Boost: A Conversation on Thinking, Memory and Parkinson’s (Webinar)
Hear our expert panelists discuss thinking and memory changes that can happen in Parkinson’s.
Podcast: New to Parkinson’s? Steps to Take Today (Webinar)
Hear our expert panelists offer practical tips for navigating a new Parkinson’s diagnosis.
Experts Discuss: Thinking and Memory, Parkinson's and a Pandemic
Our experts share information, strategies and tips for living with or caring for someone with mild thinking and memory changes.
Podcast: Night Fight with Parkinson’s: Acting Out Dreams, Insomnia and Other Sleep Issues (Webinar)
Hear our expert panelists offer practical tips and strategies for managing sleep issues in Parkinson’s disease.
Thinking about Cognitive Changes in Parkinson’s (Ask the MD Podcast)
Hear from our on-staff movement disorder specialist about the latest in Parkinson’s care and research.
Milestones and Momentum in Parkinson’s Research (Part 2)
Listen to part two of our conversation reviewing research highlights from the 20-year history of The Michael J. Fox Foundation. And learn about the next chapter the Foundation is just beginning to write.
Podcast: Calling All Care Partners: Managing Disease and Burnout in 2020 (Webinar)
Hear our panelists offer practical tips and resources for caregiving in Parkinson’s.
Milestones and Momentum in Parkinson’s Research (Part 1)
Tune in and walk down memory lane as Foundation leaders reflects on 20 years of milestones and momentum in Parkinson’s research.
Podcast: What's Next for Parkinson's: Big Trials, New Treatments and Steps toward Prevention (Webinar)
Our panelists share the momentum happening in Parkinson’s research and what’s on the horizon in 2021.
Visiting Loved Ones Who Have Parkinson’s during the Pandemic (Ask the MD Podcast)
Hear from our on-staff movement disorder specialist about the latest in Parkinson’s care and research.
Coming Soon (Part 2): Previewing the Foundation’s Virtual Offerings for You and Your Family
Listen to the second part of our fall preview as Foundation staff recap recent events and look forward to what activities and offerings are right around the corner.
Podcast: What to Watch This Election Season: A Roll Call of Parkinson’s Policy Priorities (Webinar)
This election season, we review what’s on the ballot and how these decisions impact the Parkinson’s community.
Podcast: Pursuing a Game-changing Brain Scan for Parkinson's (Ask the PhD Video)
Michael J. Fox Foundation staff discuss brain scans for Parkinson’s.
In Conversation with MJFF Board Member Jeff Keefer — “Off” Time, New PD Drugs and Research (Ask the MD Podcast)
Hear from our on-staff movement disorder specialist and her guest, MJFF Board Member Jeff Keefer, diagnosed with Parkinson’s in 2007, about PD care and research.
Podcast: Is Parkinson’s Inherited? (Webinar)
Listen to our panelists discuss what we know about Parkinson’s genetics and how genetic discoveries may lead to new treatments to stop or prevent disease.
Podcast: New Technologies to Treat Parkinson’s (Ask the PhD Video)
Michael J. Fox Foundation staff discuss devices in testing to treat gait freezing and swallowing problems.
Coming Soon (Part 1): Previewing the Foundation’s Virtual Offerings for You and Your Family
In this episode of The Michael J. Fox Foundation Parkinson's Podcast, we roll out the “orange carpet” so to speak and give you a first look at the virtual activities, events and new resources the Foundation is putting together for the fall.
A virtual run/walk. A fireside chat with Michael J. Fox. And much, much more. Listen as our panelists give you an insider update on what’s coming down the pike and how you and your family can take part. Everyone here at the Foundation looks forward to conne
Exercise and Parkinson’s (Ask the MD Podcast)
Hear from our on-staff movement disorder specialist about the latest in Parkinson’s care and research.
Podcast: Environment's Role in Parkinson’s Disease (Webinar)
Listen to our panelists discuss how environmental factors may lead to Parkinson’s and policies to limit those exposures.
Inclusivity in Parkinson's Research and Care: Why It Matters in Speeding a Cure
In this episode of The Michael J. Fox Foundation Parkinson's Podcast, we explore the intersection of race and Parkinson’s in both the lived experience of obtaining care for the disease and how that translates to research.
Listen as our panelists have a candid conversation about the value of inclusivity to advance the field’s understanding of the disease and ultimately, more scientific breakthroughs. And learn about how the Foundation is working today to break down barriers to recruit and retai
Why Your Advocacy Is Key to Advancing Parkinson's Priorities
In this episode of The Michael J. Fox Foundation Parkinson's Podcast, we discuss the importance of voicing your Parkinson’s priorities on Capitol Hill and how that might look different during a pandemic. Stepping into his new role as host of the podcast, Foundation Patient Council member Larry Gifford leads a conversation with Ted Thompson, JD, Senior Vice President of Public Policy at MJFF, and Israel Robledo, MJFF Patient Council member and policy advocate, about:
Why what happens in Washingt
Podcast: The Pandemic and Parkinson’s: COVID-19 Impact on Disease, Care and Community (Webinar)
Listen to our panelists discuss results from our Fox Insight survey on the coronavirus and Parkinson's disease.
Six Tips for Your First Year with Parkinson’s (and Beyond!) (Ask the MD Podcast)
Hear from our on-staff movement disorder specialist about the latest in Parkinson’s care and research.
Podcast: Moving with Mood Changes in Parkinson’s: A Look at Depression and Anxiety in PD (Webinar)
Listen to our panelists discuss how depression and anxiety in Parkinson’s impacts life and care.
COVID-19 Limited Series: Keeping Connected during the Pandemic When You Have Parkinson’s
Larry Gifford and guests explore ways to stay connected and ease anxiety while living with Parkinson’s in a time of uncertainty.
COVID-19 Limited Series: Finding Positivity with Parkinson’s in a Pandemic
Larry Gifford and guests break down the importance of keeping a healthy mind and body after a Parkinson’s diagnosis and especially during COVID-19.
COVID-19 Limited Series: The Pandemic and Parkinson’s Research
Larry Gifford and expert guests discuss how COVID-19 is affecting Parkinson’s research.
COVID-19 Limited Series: The Pandemic and Your Parkinson’s Care
In our first episode, we dive into practical tips for managing your Parkinson’s during COVID-19. Michael J. Fox Foundation Patient Council member Larry Gifford leads a conversation with Rachel Dolhun, MD, a board-certified movement disorder specialist and Vice President of Medical Communications at MJFF, and, Katie Amodeo, a movement disorder specialist at the University of Rochester and a graduate of the Edmond J. Safra Fellowship in Movement Disorders, about:
Getting the most out of telemedici
Podcast: Living in the Moment when the Moment Is Unprecedented (Webinar)
Listen to our panelists discuss ways to manage stress, anxiety and uncertainty.
Information on Coronavirus for the Parkinson's Community (Webinar)
Listen to our panelists discuss how the coronavirus could impact people with Parkinson’s and actions you can take to manage new changes and challenges.
Podcast: Love, Sex and Parkinson’s (Webinar)
Listen to our expert panelists discuss sexual changes women and men with Parkinson’s can experience.
Pain and Parkinson’s (Ask the MD Podcast)
Hear from our on-staff movement disorder specialist about the latest in Parkinson’s care and research.
Podcast: Eating Well with Parkinson’s Disease (Webinar)
Listen to our expert panelists discuss guidelines and considerations for a healthy diet with Parkinson’s.
Podcast: Ask Us Anything: Our Doctors Take Your Questions (Webinar)
Listen to our on-staff movement disorder specialist and research leads answer your questions.
Podcast: Being a Care Partner in Parkinson’s (Ask the MD Video)
Hear from our on-staff movement disorder specialist about the latest in Parkinson’s care and research.
Podcast: Inflammation’s Role in Parkinson’s (Ask the PhD Video)
Foundation staff discuss how inflammation can be both bad and good and how studying its connection to Parkinson’s could help define, measure and treat disease.
Podcast: Medical Marijuana and Other Alternative Therapies
Listen to our expert panelists talk about medical marijuana, and other complementary therapies, for Parkinson’s disease.
Podcast: Medical Marijuana and Parkinson’s Disease
Hear from our on-staff movement disorder specialist about the latest in Parkinson’s care and research.
Podcast: Thinking and Memory Problems in Parkinson’s
Listen to our expert panelists talk about cognitive changes in Parkinson’s, strategies to reduce them and research toward new therapies.
Podcast: Update on Stem Cell Therapies for Parkinson’s Disease
Listen to our expert panelists talk about stem cells as a research tool and potential therapy for Parkinson’s.
Podcast: Stem Cells and Parkinson’s Disease
Hear from our on-staff movement disorder specialist about the latest in Parkinson’s care and research.
Podcast: Young-onset Parkinson’s Disease
Hear from our on-staff movement disorder specialist about the latest in Parkinson’s care and research.
Podcast: Immune System’s Role in Parkinson’ s
Panelists discuss how inflammation may play a role in Parkinson’s and treatments using immune system properties against disease.
Podcast: Looking Deep into Cells for the Answers to Parkinson's
Scientists discuss how reading the sequence of genes and proteins can help better define, measure and treat Parkinson's disease.
Podcast: Repurposing Disappointments Impact on Parkinson's Drug Development
MJFF and NINDS leaders discuss results from trials of a dietary supplement and a blood pressure drug for Parkinson's and what is next in the pipeline.
Podcast: Vision Problems in Parkinson's Disease
A brief summary of this episode
Podcast: Latest in Parkinson's Research
The Michael J. Fox Foundation's Dr. Marco Baptista, Sohini Chowdhury and Dr. Rachel Dolhun talk to Dave Iverson about recent findings and new programs.
Podcast: Q&A on Latest in Parkinson's Research
Staff from The Michael J. Fox Foundation answer questions from the audience at a recent panel discussion on progress in Parkinson's research.
Podcast: Better Conversations and Care
In this Third Thursdays Webinar, physicians and people with Parkinson's discuss strategies to make doctor visits more effective and efficient.
Podcast: Deep Brain Stimulation and Focused Ultrasound
Listen to our expert panelists talk about medical devices that can manage certain Parkinson's symptoms.
Podcast: Levodopa Myths
Listen to Dr. Rachel Dolhun tackle widespread myths about levodopa.
Addressing Gait and Balance Issues in Parkinson’s
Our panelists in this Third Thursdays Webinar discuss common Parkinson's motor symptoms and emerging treatments to target them.
Podcast: Sleeping Well with Parkinson's
https://www.michaeljfox.org/foundation/news-detail.php?new-parkinson-drug-comes-to-market-after-early-investment-from-the-michael-fox-foundation
Podcast: Parkinson's Will Double by 2040: Are We Ready?
Hear our panelists and co-authors of the paper "The Parkinson's Pandemic" discuss reasons for this global rise and strategies to contend with the issue.
Podcast: Research Year in Review and Look Ahead
Listen to our expert panelists discuss the progress made in PD research over the last year and what to look forward to in 2019.
Podcast: Visiting with Family Members Who Have Parkinson's
Listen to Dr. Rachel Dolhun's tips for making the most of holiday visits with family who have Parkinson's.
Podcast: Treating Parkinson's 'Off' Episodes
In our latest podcast, listen to our Third Thursday Webinar panelists discuss 'off' times in Parkinson's.
Podcast: How Genetic Discoveries Lead to Parkinson's Therapies
Listen to experts discuss the relationship between genetics and Parkinson's disease.
Podcast: Dystonia Causes and Care
Listen to experts discuss the causes of dystonia and various treatment options.
Podcast: Our MD Talks Muscle Cramps with Parkinson's
Hear from our on-staff movement disorder specialist about dystonia: a symptom of Parkinson's and standalone disorder that causes painful muscle cramps.
Podcast: Urinary Problems in Parkinson's Disease
Listen to experts discuss treatments for urinary problems in Parkinson's disease.
Podcast: Putting the Parkinson's Puzzle Together
One of our MJFF scientists talks about piecing together the many factors that play a role in Parkinson's and what can help us continue making progress.
Podcast: What Is a Protein Anyway?
MJFF scientist Dr. Brian Fiske talks about what goes wrong with cellular proteins, how we may fix them and if you should eat less protein.
Podcast: Addressing a Parkinson's Pandemic
Dr. Ray Dorsey from the University of Rochester discusses the rise in Parkinson's and how we can take steps to prevent onset and get people the care they need.
Podcast: 2017 Parkinson's Research Year in Review
Missed our Year in Review webinar? Catch up with this recording and hear our panelists recap new potential Parkinson's treatments in clinical testing.
Podcast: Cells' Recycling System
Autophagy is how cells break down and recycle damaged parts. We explain the link to Parkinson's and how treating autophagy may slow or stop disease.
Podcast: Your Day Is Our Data
The online study Fox Insight analyzes data on life with disease from tens of thousands of people, with or without PD, to influence research focus and design.
Podcast: Sniff Test for Parkinson's Disease
Measuring a person's scent or eye movements could lead to earlier PD diagnosis.
Podcast: Measuring Feeling and Functional Impact of Dyskinesia
How does dyskinesia impact people with PD? An MJFF-funded measurement scale captured those perceptions and helped a new drug get approved to treat it.
Podcast: Teaching Old Drugs New Tricks
Scientists are testing drugs used for high blood pressure and diabetes for their effects on Parkinson's disease. MJFF CEO Todd Sherer, PhD, discusses this tactic of drug repurposing.
Podcast: Is Parkinson's an Autoimmune Disease?
In the latest in our "Getting to a Cure: Science behind the Search" series, we cover the proposed connection between sticky protein alpha-synuclein and the immune system.
Podcast: Young-Onset Parkinson's Disease
Nancy Mulhearn, who was diagnosed with Parkinson’s at age 44, shares her experiences with the disease.
Podcast: Sleep Disturbances in Parkinson's
Carlos Singer, MD, of the University of Miami discusses common sleep problems in Parkinson's and how to treat them.
Podcast: Urinary Problems in Parkinson's Disease
Urinary function is governed by the body's autonomic nervous system. In Parkinson's, urinary function can be thrown off balance, but urinary problems aren't always recognized by patients.
Learn more at https://www.michaeljfox.org/clinical
Podcast: Parkinson's Genetics
Barbara and Jay Robinson discuss their decision to participate in Parkinson's genetics research.
Podcast: Gut Bacteria and Parkinson's Connection
Sarkis Mazmanian, PhD, of CalTech discusses what we know about the gut bacteria and Parkinson's connection in our "Getting to a Cure: The Science behind the Search" podcast series.
Podcast: Parkinson's Common Denominator -- A Sticky Protein
Dr. Jamie Eberling, PhD, dicusses alpha-synuclein, a protein that clumps in brain cells of nearly everyone with Parkinson's disease.
Podcast: Choosing Parkinson's Medications
In this podcast, Thomas Davis, MD, of Vanderbilt University Medical Center, speaks about how doctors and patients work together to create a medication regimen.
Blood Pressure and Parkinson's
Dr. Anna Hohler speak to MJFF about blood pressure changes and Parkinson's disease.
Podcast: Learning the Language of LRRK2
In this podcast, MJFF staff scientist Marco Baptista, PhD, discusses the genetics and biology of LRRK2 and the role of the Foundation in advancing development of LRRK2 therapeutics.
Podcast: Atypical Parkinsonisms
Alex Pantelyat, MD, assistant professor of neurology at Johns Hopkins University, speaks to MJFF about atypical parkinsonisms and their relation to Parkinson’s disease.
Podcast: Pain in Parkinson's
In this podcast, Dr. Julie Pilitsis speaks about Parkinson's pain and its connection to fatigue.
Podcast: Treating Parkinson's Hallucinations and Delusions
Dr. Rachel Dolhun explores Parkinson's disease psychosis, including hallucinations and delusions, and discusses treatments for this symptom.
Podcast: Parkinson's Personalized Medicine
MJFF's Dr. Brian Fiske discusses how we may be able to target treatments to the "type" of Parkinson's one has, much like is done in cancer care.
Podcast: Efforts Toward Earlier Diagnosis
MJFF's Samantha Hutten, PhD, talks about how researchers are developing methods to identify people with PD earlier in the disease process, which could help test therapies to slow or stop Parkinson's.
Podcast: Stem Cell-Derived Therapy 2.0
In our latest podcast, Dr. Ole Isacson, MD, PhD, a professor of neurology and neuroscience at Harvard Medical School, discusses stem cells and Parkinson's disease.
Podcast: What Causes Dyskinesia?
In our latest podcast, Christopher Bishop, PhD, discusses what may cause involuntary movements called dyskinesia with long-term Parkinson's disease and medication use.
Podcast: A Tool to Manage Tremor and Isolation
In our latest podcast the creator of Liftware talks about how he developed his tremor-stabilizing technology and how it helps people with Parkinson's fight isolation.
Podcast: Parkinson's Research Roundup - 2015 Year in Review
Mark Frasier, PhD, Senior Vice President of Research Programs at MJFF, discusses Parkinson's disease research highlights from 2015.
Podcast: Keeping Step with Parkinson’s: Balance, Posture and Gait
Dr. Chris Hass of the University of Florida explores balance, posture and gait issues and how to best protect from falls.
Podcast: The Arts Impact on Parkinson's Disease
In our latest podcast, MJFF Contributing Editor Dave Iverson speaks with guest panelists about what dance offers people living with Parkinson's.
Podcast: Therapies that May Slow or Stop Parkinson’s
MJFF CEO Todd Sherer, PhD, discusses therapies in human testing that have potential to slow or stop Parkinson's disease.
Podcast: The Dystopian Experience of Dystonia
In our latest podcast Allison London shares how her dystonia has impacted her life and why she's on a mission to raise awareness.
Podcast: Journalist Explores the Paths of Parkinson’s Research after His Own Diagnosis
Jon Palfreman has a new book exploring the history of Parkinson's research. He was diagnosed with PD in 2011 after spending years investigating rare cases of the disease for a documentary and book.
Podcast: Parkinson’s Cognitive Issues and Treatment
MJFF's Dr. Jamie Eberling talks to Dave Iverson about what cognitive symptoms people with PD may experience and what new therapies are in development.
Podcast: Complementary and Alternative Approaches for Parkinson’s
Dr. Laurie Mischley discusses some of the challenges that research into complementary and alternative approaches to managing Parkinson's face.
Podcast: "Find Your Own Summit"
MJFF Contributing Editor Dave Iverson recently sat down with Sam to talk about how he turned his athletic talents into a career that honors his mother and the millions of others affected by PD.
Podcast: Improving Deep Brain Stimulation
Our latest podcast covers how researchers are investigating ways to expand the current capabilities of deep brain stimulation.
Podcast: How Genetics Has Transformed Parkinson’s Study
Geneticist Dr. Tatiana Foroud explains how the study of Parkinson's genetics can help develop new therapies.
Podcast: How Can Exercise Help Manage Parkinson’s?
Dr. Lisa Shulman from the University of Maryland discusses how exercise may help manage Parkinson's motor and non-motor symptoms in our latest podcast.
Podcast: Parkinson’s Research Year in Review
In our latest podcast. MJFF CEO Dr. Todd Sherer discusses the progress in Parkinson's research seen this year.
Podcast: Strategies for Stopping Parkinson’s
We say Parkinson’s disease is different for each person, but there are a couple things all people with PD share: Lewy bodies and dopamine loss.
Podcast: What Is Dystonia?
Dystonia is the third most common movement disorder and a symptom of Parkinson's disease. Bonnie Strauss talks about her experience, and Dr. Rachel Dolhun shares what we know about dystonia.
Podcast: Meet the Newest Member of Your Care Team: The Smartwatch
Dr. William Marks talks to Dave Iverson about how wearable devices may help people with Parkinson's monitor their disease and help researchers test new therapies.
Podcast: Six New Genetic Risk Factors for Parkinson's Identified
Scientists have found six new gene variants associated with Parkinson's, which could point to new treatment paths.
Podcast: What Causes "Off" Episodes?
CEO Todd Sherer, PhD, talks to Dave Iverson about why levodopa loses efficacy over time and new therapies in development to even out on/off cycles.
Podcast: Alzheimer’s and Parkinson’s, What’s the Connection?
Mark Frasier, PhD, VP of research programs at MJFF, discusses what we know about the overlap between Alzheimer's and Parkinson's diseases.
Podcast: How Parkinson’s Variability Could Point to Personalized Treatments
The experience of Parkinson's disease is different for each patient. Studying that variability may allow researchers to develop personalized treatments for different subtypes of PD.
Podcast: Drug That May Slow Parkinson’s Progression Granted $23 Million from NIH for Phase III Testing
Tanya Simuni, MD, principal investigator of the STEADY-PD, and MJFF CEO Todd Sherer talk about the study of isradipine, recently granted $23 million from the NIH for Phase III testing.
Podcast: What Do Other Movement Disorders and Parkinson's Have in Common?
Biological commonalities between Parkinson's disease and other movement disorders could help researchers develop therapies that could apply across diagnostic barriers.
Podcast: Parkinson’s Disease: What Else Goes Wrong?
Charles Adler, MD, PhD, talks to Dave Iverson about autonomic dysfunction symptoms and their place in research in our latest podcast.
Podcast: The Long Road to Diagnosis
Dr. Kathleen Shannon of Rush University talks to Dave Iverson about the need for a definitive Parkinson's diagnostic test, what researchers are doing to develop one and how patients can help.
Podcast: Inosine May Hold Potential for Parkinson’s Disease, but Patients Urged to Act with Caution
The SURE-PD study published in JAMA Neurology reports that with medical supervision, it is possible to safely raise levels of the antioxidant urate by taking the urate precursor inosine.
Podcast: Research Year in Review
The Michael J. Fox Foundation Contributing Editor Dave Iverson speaks with Kalpana Merchant, PhD of Eli Lilly and Company about the latest in Parkinson's disease research.
Podcast: Refining Deep Brain Stimulation
Researchers are improving on the existing DBS technology—an implanted electrode delivers electrical pulses to stimulate or block brain signals—and how we use it.
Podcast: Pursuing a Tool to Visualize Alpha-Synuclein in the Brain
Levels of alpha-synuclein in the brain—measured through imaging tools—could be a biomarker that would help researchers diagnose the disease better and test potential therapies faster.
Podcast: Whatever Happened to Stem Cells?
Contributing Editor Dave Iverson reports on the new technology that partnership will employ and the current state of stem cell research in Parkinson’s disease. He speaks
Podcast: Prescribing Exercise to Treat Parkinson’s
While much research into Parkinson’s disease (PD) focuses on improving dopamine supply, there is an emerging scientific understanding that Parkinson’s goes well beyond the dopamine system.
Podcast: Quicker Progress in Genetics
The evolution of our understanding of genetics’ role in Parkinson’s disease (PD) and how that understanding will translate into drug discovery is the topic of a new podcast and upcoming Webinar.
Podcast: As Fox Trial Finder Reaches 20,000 Volunteers, One Volunteer Shares Her Story
Fox Trial Finder volunteer Gwen Schroeder recounts her first clinical trial experience to MJFF contributing editor Dave Iverson.
Podcast: Improved Levodopa Delivery with Inhaled Formulation
Dave Iverson speaks with the CEO of Civitas, Glenn Batchelder, and MJFF staffer Maurizio Facheris, MD, MSc to learn more about how the drug works, as well as next steps.
Podcast: PPMI Preliminary Research Begins to Provide Clues in Biomarker Search
Dave Iverson speaks with Foundation staffer Mark Frasier to learn more about some of the early findings from the study.
Podcast: Discussing the Ceregene Clinical Trial Results
Dave Iverson reports on recent disappointing clinical trial results of Ceregene’s trophic factor therapy CERE-120.
Podcast: Could a Nicotine Patch Slow the Progression of Parkinson’s Disease?
Studies have long suggested that smokers may be less likely to get Parkinson's. Here, Dave Iverson speaks with a researcher investigating the potential of nicotine patches as a PD treatment.
Podcast: The State of Parkinson’s Disease Research
2013 could be a pivotal year in PD research, with expected developments on a variety of fronts. In this podcast, Dave Iverson speaks with Foundation staffers about some of that lies ahead.
Podcast: The Decision to Get Genetically Tested
Emerging evidence over the past 15 years has led researchers to believe that genetics plays a far greater role in Parkinson’s disease (PD) than was once thought.
Podcast: Engaged Parkinson's Patients Are the Answer to a Cure
Patients have always been at the heart of what we do at The Michael J. Fox Foundation. Our dedication to improving patients’ quality of life has shaped our research priorities.
Podcast: Limiting On-Off Periods in Parkinson's Medications
While levodopa is the gold standard therapy for Parkinson's disease (PD), current delivery methods have their limitations.
Podcast: What is the Connection Between Genetics and Environment in Parkinson's?
Understanding the genetics of Parkinson’s disease could be a game changer in developing new treatments for the disease. Especially when it comes to two genetic targets: LRRK2 and alpha-synuclein.
Podcast: Dave Iverson & Dr. Todd Sherer: New Approaches to Treating Dyskinesia
Dyskinesia refers to the excessive and uncontrollable movements that are a side effect of long-term dopamine replacement therapy in patients with Parkinson's disease (PD).
Podcast: Teva Seeks Label Change for Azilect
This fall, The FDA recommended that Teva Neuroscience’s drug rasagiline, brand name Azilect, should not be granted status “to slow the clinical progression of PD.”
Podcast: A Vaccine Approach to Treating Parkinson's Disease
This past October, Austrian biotech AFFiRiS announced $1.5 million in funding from MJFF for an early stage clinical trial of a first-of-its-kind vaccine approach to treating Parkinson's disease (PD).